Firtecan pegol Completed Phase 1 Trials for Advanced Solid Tumors / Lymphoma
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Not Available | 1 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT00520637 | A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-01) |